References
- 1. Nicholson KG, Wood JM, Zambon M. Influenza. Lancet. 2003 Nov 22;362(9397):1733-45. DOI: 10.1016/ S0140-6736(03)14854-4
- 2. Hay AJ, Gregory V, Douglas AR, Lin YP. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci. 2001 Dec 29;356(1416):1861-70. DOI: 10.1098/rstb.2001.0999
- 3. World Health Organization. Influenza. Wkly Epidemiol Rec. 1978;53:21-4.
- 4. Nakajima K, Desselberger U, Palese P. Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature. 1978;274:334-9. DOI: 10.1038/274334a0
- 5. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, et al. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009 Jun 18;360(25):2605-15. DOI: 10.1056/NEJMoa0903810
- 6. Kanegae Y, Sugita S, Endo A, Ishida M, Senya S, Osako K, et al. Evolutionary pattern of the hemagglutinin gene of influenza B viruses isolated in Japan: cocirculating lineages in the same epidemic season. J Virol. 1990;64:2860-5.
- 7. Rota PA, Hemphill ML, Whistler T, Regnery HL, Kendal AP. Antigenic and genetic characterization of the haemagglutinins of recent cocirculating strains of influenza B virus. J Gen Virol 1992;73:2737-42. DOI: 10.1099/0022-1317-73-10-2737
- 8. National Institute of Public Health, Romania. Influenza, ARI and SARI surveillance methodology, 2012-2013. [Metodologia de supraveghere a gripei, infectiilor respiratorii acute si SARI pentru sezonul 2012-2013]. Available on: http://www.insp.gov.ro/cnscbt/index.php?option=com_docman&task=cat_view&gid=41&Itemid=10 (accessed on 7/01/2014).
- 9. Valenciano M, Ciancio Bc, I-MOVE study team. I-MOVE: a European network to measure the effectiveness of influenza vaccines. Euro Surveill. 2012;17(39):11-21.
- 10. European Centre for Disease Prevention and Control (ECDC), Protocol for case-control studies to measure pandemic and seasonal influenza vaccine effectiveness in the European Union and European Economic Area Member States, Technical document. Available from: http://www.ecdc.europa.eu/en/publications/Publications/0907_TED_Influenza_AH1N1_Measuring_Influenza_Vaccine_Effectiveness_Protocol_Case_Control_Studies.pdf
- 11. European Commission. Commission Decision 2009/363/EC of 30 April 2009 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council, OJ L 110, 1.5.208, p. 58. Available on line:http://eur-lex.europa.eu/LexUriServ/Lex- UriServ.do?uri=OJ:L:2009:110:0058:0059:EN:PDF
- 12. Biere B, Bauer B, Schweiger B. Differentiation of Influenza B Virus Lineages Yamagata and Victoria by Real-Time PCR. J Clin Microbiol. 2010;48 (4):1425-7. DOI: 10.1128/JCM.02116-09
- 13. World Health Organization. Indentification of the haemagglutinin subtype of viral isolates by haemagglutination inhibition testing. Manual for the laboratory diagnosis and virological surveillance of influenza, WHO Press. Geneva. 2011;43-59.
- 14. Necula G, Mihai ME, Sbarcea CE, Dinu S, Lupulescu E, Ceausu E, et al. Overview of influenza virus antiviral resistance in Romania in the last four epidemic seasons - phenotyping, genotyping and molecular analysis study. Rev Romana Med Lab. 2011;19(3):227-40.
- 15. Pitigoi D, Lupulescu E, Alexandrescu V, Baetel AE, Sbarcea C, Ionita E, et al. The effectiveness of seasonal influenza vaccine in persons older than 65 years in Romania. Case-control pilot study I-MOVE, 2008-2009, [Eficacitatea vaccinului gripal sezonier la persoanele cu varsta peste 65 de ani din Romania. Studiul pilot caz-martor I-MOVE, 2008-2009]. Bacteriol Virusol Parazitol Epidemiol. 2009 aprilie-iun;54(2):59-67.
- 16. Pitigoi D, Ivanciuc AE, Necula G, Lupulescu E, Alexandrescu V, Savulescu C. Influenza vaccine effectiveness to prevent medically attended laboratory confirmed influenza during season 2010-2011 in Romania: a case control study. Rev Romana Med Lab. 2012;20(2):127-34.
- 17. World Health Organization Influenza Centre London. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere 2014, 23rd - 25th September 2013.
- 18. World Health Organization. Recommended composition of influenza virus vaccines for use in the 2012-2013 northern hemisphere influenza season. Geneva World Health Organisation http://www.who.int/influenza/vaccines/virus/recommendations/2012_13_north/en/(accessed on 7/01/2014).
- 19. World Health Organization. Meetings of the WHO working group on surveillance of influenza antiviral susceptibility. Wkly Epidemiol Rec. 2012 Sep 28;87(39):369-74.
- 20. Pistol A, Popescu R. ARI and ILI surveillance in Romania, week 40/2012-week 20/2013 [Supravegherea infectiilor respiratorii acute si a gripei in Romania, S 40/2012-S20/2013]. Available at: http://www.insp.gov.ro/cnscbt/index.php?option=com_docman&Itemid=49 (accessed on 7/01/2014).
- 21. European Centre for Disease Prevention and Control (ECDC). Weekly influenza surveillance overview, April 2013. http://www.ecdc.europa.eu/en/publications/Publications/influenza-weekly-surveillance-overview-26-apr-2013.pdf
- 22. World Health Organization. Summary of the 2012-2013 influenza season in the WHO European Region. 2013 http://www.euro.who.int/__data/assets/pdf_file/0011/195824/Summary-of-the-20122013-influenza-season-in-the-WHO-European-Region-final.pdf
- 23. Rykkvin R, Kilander A, Dudman SG, Hungnes O. Within- patient emergence of the influenza A(H1N1)pdm09 HA1 222G variant and clear association with severe disease, Norway. Euro Surveill. 2013 Jan 17;18(3). pii: 20369.
- 24. Public Health England. Surveillance of influenza and other respiratory viruses, including novel respiratory viruses, in the United Kingdom: Winter 2012/13. Available at: http://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139321787 (accessed on 7 January 2014).
- 25. Kissling E, Valenciano M, Buchholz U, Larrauri A, Cohen JM, Nunes B, et al. Influenza vaccine effectiveness estimates in Europe in a season with three influenza type/subtypes circulating: the I-MOVE multicentre case-control study, influenza season 2012/13. Euro Surveill. 2014;19(6):pii=20701.
- 26. Savulescu C, Valenciano M, de Mateo S, Larrauri A; cycEVA Study Team. Estimating the influenza vaccine effectiveness in elderly on a yearly basis using the Spanish influenza surveillance network--pilot case-control studies using different control groups, 2008-2009 season, Spain. Vaccine. 2010;28(16):2903-7. DOI: 10.1016/j.vaccine.2010.01.054